Related Experiment Videos
[Histocompatibility antigens in amyotrophic lateral sclerosis patients]
Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)
|January 1, 1984
Summary
The study found that HLA B18 antigen is linked to increased lateral amyotrophic sclerosis risk. HLA B27 and BW35 antigens influence disease progression, while HLA B8 and B7 antigens are less common in patients.
Area of Science:
- Immunogenetics
- Neurology
- Human Leukocyte Antigens (HLA)
Context:
- Lateral amyotrophic sclerosis (LAS) is a progressive neurodegenerative disease.
- Understanding the genetic factors influencing LAS is crucial for diagnosis and treatment.
- Human Leukocyte Antigen (HLA) genes play a significant role in immune responses and disease susceptibility.
Purpose:
- To investigate the association between specific HLA antigens and the risk of developing lateral amyotrophic sclerosis.
- To explore the relationship between HLA antigen profiles and the characteristics of disease progression in LAS patients.
Summary:
- A study of 55 lateral amyotrophic sclerosis patients identified a correlation between HLA B18 antigen and increased disease risk.
- Disease progression in LAS patients was found to be associated with HLA B27 and BW35 antigens.
- A decreased incidence of HLA B8 and B7 antigens was observed in the patient cohort.
Impact:
- These findings contribute to understanding the immunogenetic basis of lateral amyotrophic sclerosis.
- Identifying specific HLA associations may aid in risk stratification and personalized treatment approaches for LAS.
- Further research into HLA antigen roles could lead to novel diagnostic biomarkers or therapeutic targets for neurodegenerative diseases.